Home » Stocks » APDN

Applied DNA Sciences, Inc. (APDN)

Stock Price: $7.18 USD 0.00 (0.00%)
Updated November 27, 1:00 PM EST - Market closed
Pre-market: $7.33 +0.15 (2.09%) Nov 30, 4:03 AM

Stock Price Chart

Key Info

Market Cap 36.93M
Revenue (ttm) 3.29M
Net Income (ttm) -10.44M
Shares Out 5.14M
EPS (ttm) -3.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $7.18
Previous Close $7.18
Change ($) 0.00
Change (%) 0.00%
Day's Open 6.79
Day's Range 6.60 - 7.23
Day's Volume 271,749
52-Week Range 2.80 - 15.21

More Stats

Market Cap 36.93M
Enterprise Value 28.24M
Earnings Date (est) Jan 1, 1970
Ex-Dividend Date n/a
Shares Outstanding 5.14M
Float n/a
EPS (basic) -3.92
EPS (diluted) -3.60
FCF / Share -2.18
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 442,369
Short Ratio 3.00
Short % of Float n/a
Beta 1.58
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 11.22
PB Ratio 4.18
Revenue 3.29M
Operating Income -10.35M
Net Income -10.44M
Free Cash Flow -9.99M
Net Cash 8.68M
Net Cash / Share 1.69
Gross Margin 137.11%
Operating Margin -314.44%
Profit Margin -317.30%
FCF Margin -303.67%
ROA -76.25%
ROE -290.04%
ROIC -733.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(199.44% upside)
Current: $7.18
Target: 21.50
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth38.06%-17.85%13.49%-53.53%231.05%33.64%9.79%91.43%86.37%-
Gross Profit4.512.703.673.028.622.722.041.850.970.52
Operating Income-9.12-11.65-12.82-12.20-7.85-12.27-10.18-6.51-8.06-7.12
Net Income-8.62-11.69-12.86-12.18-11.88-13.07-17.69-7.15-10.52-7.91
Shares Outstanding0.920.740.660.590.470.340.
Earnings Per Share-9.69-15.86-19.60-20.40-25.20-38.80-60.40-29.60-71.99-71.99
Operating Cash Flow-6.86-6.92-7.48-9.90-6.97-8.51-7.87-3.96-3.76-2.46
Capital Expenditures-0.07-0.27-0.15-0.67-0.35-0.23-0.64-0.16-0.09-
Free Cash Flow-6.93-7.18-7.62-10.56-7.32-8.74-8.51-4.12-3.85-2.46
Cash & Equivalents0.621.723.024.547.381.456.410.762.770.03
Total Debt1.551.59---1.80--3.732.04
Net Cash / Debt-0.920.143.024.547.38-0.356.410.76-0.96-2.02
Book Value-0.840.756.8610.3712.57-1.474.620.76-1.00-1.60
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Applied DNA Sciences, Inc.
Country United States
Employees 51
CEO James A. Hayward

Stock Information

Ticker Symbol APDN
Stock Exchange NASDAQ
Sector Industrials
Industry Security & Protection Services
Unique Identifier NASDAQ: APDN


Applied DNA Sciences engages in polymerase chain reaction-based DNA manufacturing that enables in vitro diagnostics, and pre-clinical nucleic acid-based therapeutic drug candidates in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA. It also provides Smart DNA, a tagging solution for vehicle and home asset marking, as well as for commercial and government use; Beacon locked optical markers, which create a protected covert screening tool that can be adapted to packaging, security labels, and high?value assets through inks, varnishes, and coatings; and SigNify IF portable DNA readers. In addition, the company offers Applied DNA Sciences Portal, a software platform that enables customers to manage the security of company-marked goods; and DNA Transfer Systems and Cannabis Tracking System for real-time monitoring. Further, it provides CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products; and Triathlon PCR systems that allow for the large-scale production of specific DNA sequences. Additionally, the company offers contract research services; and various RNA based drug and biologic customers for preclinical studies. It also develops tests in virology, for the detection of COVID-19, and in oncology, for the detection and enumeration of invasive circulating tumor cells. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.